RA Capital's sustained accumulation at $8.95–$9.99 suggests a strong conviction in ARTV's near-term value. Traders should watch for upcoming clinical data readouts or partnership announcements that could catalyze the stock. The prior cluster of $1.0M in buys on July 23–24 amplifies this signal, consider building a position with a stop below the $8.95 cluster low.
ARTV drugs
ARTV drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 29 $10.02entry
- T+1 · 4mo ago +4.09%α +2.42% · $10.43
- T+5 · 3mo ago +15.67%α +10.14% · $11.59
- T+20 · 3mo ago +17.47%α +12.44% · $11.77
- T+60 · 26d ago −38.12%α −43.11% · $6.20
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
RA Capital Management, a 10% owner and director, made a series of open-market purchases totaling ~$3.07M over 7 days (July 17–24), with the bulk at $9.55–$9.99 per share. This is a conviction buy from a sophisticated healthcare investor, representing ~1.2% of ARTV's $255M market cap, and follows a prior cluster of $1.0M in RA Capital buys on July 23–24.
Key Financial Metrics
Key Facts
- RA Capital Management (Director, 10% Owner) purchased ~313.8K shares total across 5 trades from July 17–24, 2026
- Total purchase value: ~$3.07M, representing ~1.2% of ARTV's $255M market cap
- Weighted average purchase price: ~$9.78 per share
- Prior 30-day insider activity: 9 buys totaling $4.7M, indicating sustained insider accumulation
Financial Impact
RA Capital spent ~$3.07M to acquire ~313.8K shares, ~1.2% of market cap
Risk Factors
- Biotech clinical-stage risk, no approved products; pipeline setbacks could erase value
- Insider buying does not guarantee near-term catalysts; stock may drift without news
- RA Capital is a large holder, future sales could pressure shares if thesis changes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001231919-26-000808 |
Track record
33 reports on ARTV
10 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
- Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
- Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
- Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
- Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers